Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04271709 · ClinicalTrials.gov registry record · NA

Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)

A NA study of Glaucoma and Cataract, sponsored by Columbia University.

Active
Registry status
NA
Development phase
749
Enrollment target
1
Study location

NCT04271709 is a NA study of Glaucoma and Cataract that is active but no longer recruiting, run by Columbia University. The registered enrollment target is 749 participants, below the 902-participant average among 92 other Glaucoma trials with a reported enrollment target (17% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04271709, a NA study of Glaucoma and Cataract, is active but no longer recruiting, sponsored by Columbia University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
749 participants
Enrollment target
1
Study location

Study Summary

The investigators are conducting a 5-year prospective, 2:1 cluster-randomized controlled trial, funded by the Centers for Disease Control (CDC), which provides vision screenings to underserved New York City residents living in affordable housing buildings in Harlem and Washington Heights.

Interventions

  • OTHER Usual Care
  • BEHAVIORAL Enhanced Intervention Using Patient Navigators

Study Locations (1)

New York

  • Columbia University - New York

Trial Details

FieldValue
Enrollment Target 749 participants
Start Date 2019-09-30
Est. Completion 2026-09-29
Phase NA

Sponsor

Columbia University

958 total trials

What the Registry Record Tells You About NCT04271709

The ClinicalTrials.gov registry entry for NCT04271709 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 749 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 902-participant average among 92 other Glaucoma trials with a reported enrollment target (17% lower). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Glaucoma appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.

NCT04271709 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT04271709 about?

NCT04271709 is a clinical study titled "Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)". The investigators are conducting a 5-year prospective, 2:1 cluster-randomized controlled trial, funded by the Centers for Disease Control (CDC), which provides vision screenings to underserved New York City residents living in affordable housing buildings in Harlem and Washington Heights.

What is the current status of trial NCT04271709?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 749 participants. The study started on 2019-09-30. Estimated completion is 2026-09-29.

What conditions does trial NCT04271709 study?

This clinical trial studies the following conditions: Glaucoma, Cataract, Diabetic Retinopathy, Eye Diseases, Vision Impairment and Blindness.

What interventions are being tested in trial NCT04271709?

The interventions under investigation include: Usual Care (OTHER), Enhanced Intervention Using Patient Navigators (BEHAVIORAL).

Who is sponsoring clinical trial NCT04271709?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04271709 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Glaucoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.